SYNOPSIS

The Lindau Nobel Laureate Meetings – established in 1951 – provide a globally recognized forum for exchange between Nobel Laureates and young scientists. They inspire scientific generations and build sustainable networks of young scientists around the world.

In the first part of this lecture, the speaker will discuss their experience in being nominated for and attending the Lindau Nobel Prize Meeting in Medicine and during the conference. Highlights from the meeting will be presented. In the second part, the speaker will discuss their journey in research and medicine, with a focus on drug discovery and clinical translation. Projects related to discovery of novel pharmacophores for COVID19 treatment, late-stage optimization to generate an imaging and therapeutic radiopharmaceutical for clinical trials, and development of new imaging methodologies in patients will be presented.

At the end of this session, participants will:

1. Describe the nomination process for the Lindau Nobel Prize Meeting;
2. Gain insight into several experiences at the Lindau Nobel Prize Meeting;
3. Describe how integration of multiple branches of basic, mathematical and biomedical sciences can lead to medical solutions with the potential to improve patient outcomes.